Bank of New York Mellon Corp Has $66.03 Million Holdings in Doximity, Inc. (NASDAQ:DOCS)

Bank of New York Mellon Corp increased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,137,912 shares of the company's stock after acquiring an additional 86,135 shares during the period. Bank of New York Mellon Corp owned approximately 0.61% of Doximity worth $66,033,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC increased its position in shares of Doximity by 17.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 2,269 shares of the company's stock worth $121,000 after acquiring an additional 332 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Doximity by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company's stock valued at $41,565,000 after buying an additional 25,523 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Doximity by 3.0% during the 4th quarter. Victory Capital Management Inc. now owns 34,516 shares of the company's stock worth $1,843,000 after purchasing an additional 1,016 shares in the last quarter. Atria Investments Inc grew its stake in Doximity by 6.4% in the 4th quarter. Atria Investments Inc now owns 8,975 shares of the company's stock worth $479,000 after acquiring an additional 539 shares during the period. Finally, M&T Bank Corp boosted its holdings in shares of Doximity by 6.7% in the 4th quarter. M&T Bank Corp now owns 8,601 shares of the company's stock valued at $459,000 after purchasing an additional 543 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded up $0.09 during midday trading on Tuesday, hitting $61.64. 1,168,250 shares of the stock were exchanged, compared to its average volume of 2,174,549. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21. The business's fifty day simple moving average is $57.24 and its two-hundred day simple moving average is $59.22. The company has a market capitalization of $11.58 billion, a PE ratio of 61.64, a P/E/G ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same quarter last year, the business earned $0.25 earnings per share. The company's quarterly revenue was up 17.1% compared to the same quarter last year. As a group, equities analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Buying and Selling

In other Doximity news, Director Regina M. Benjamin sold 10,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the sale, the director directly owned 16,618 shares of the company's stock, valued at approximately $997,080. The trade was a 37.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer directly owned 357,165 shares in the company, valued at $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 76,000 shares of company stock valued at $4,400,970 in the last three months. 37.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DOCS. Bank of America lifted their target price on shares of Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Mizuho cut their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday, May 16th. KeyCorp upped their target price on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research note on Monday. Morgan Stanley cut their target price on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Finally, Raymond James Financial cut their target price on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Ten investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $64.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.